Femasys Inc
NASDAQ:FEMY 2:54:35 PM EDT
| Market Cap (Intraday) | 14.77M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $1.45 |
| 50-Day MA | $1.88 |
| 200-Day MA | $2.28 |
Femasys Inc Stock, NASDAQ:FEMY
3950 Johns Creek Court, Suite 100, Suwanee, Georgia 30024
United States of America
Phone: +1.770.500.3910
Number of Employees: 27
Description
Femasys, Inc. operates as a medical device company that focuses on women's healthcare. Its products include FemVue Saline-Air Device, which creates and delivers an alternating pattern of saline and air as a continuous stream, and enables physicians to assess their patients fallopian tubes, and FemChec Pressure Management Device, which limits the maximum applied pressure while performing hysterosalpingogram. The firm offers FemCerv, an endocervical curettage device to collect a non-contaminated tissue sample for cervical cancer screening. The company was founded by Kathy Lee-Sepsick in 2004 and is headquartered in Suwanee, GA.